文献速递慢性肾脏病肾血管病与高血压

系统综述与荟萃分析:子痫前期后慢性及终末期肾病的长期风险

A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia.
PubMed 文献 · Kidney Int · 2019-05-14

该系统综述纳入21项研究,涉及110,803例子痫前期患者和2,680,929例对照,随访≥4年。荟萃分析显示子痫前期后终末期肾病风险显著增加(RR 6.35,95%CI 2.73-14.79),白蛋白尿和慢性肾脏病风险增加但未达统计学显著性。

要点

  • 子痫前期后终末期肾病风险显著增加,RR为6.35(95%CI 2.73-14.79)。
  • 白蛋白尿和慢性肾脏病风险增加但未达统计学显著性。
  • 每310例子痫前期患者需随访以发现1例终末期肾病。

核心结论

  • 子痫前期显著增加终末期肾病风险,但白蛋白尿和慢性肾脏病风险增加未达统计学显著性。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase和Cochrane Library 2000年1月至2018年3月文献。
  • 纳入标准:至少20例子痫前期患者,随访≥4年,无质量筛选或语言限制。
  • 最终纳入21篇论文,提供110,803例子痫前期病例和2,680,929例对照信息,研究间部分重叠。

主要发现

  • 子痫前期后终末期肾病风险显著增加,荟萃分析风险比(95%CI)为6.35(2.73-14.79)。
  • 白蛋白尿风险比为4.31(0.95-19.58),慢性肾脏病风险比为2.03(0.58-7.32),均未达统计学显著性。
  • 每310例子痫前期患者需随访以发现1例终末期肾病,每4例以发现1例白蛋白尿。

关键数值与推荐

  • 子痫前期后终末期肾病风险比6.35(95%CI 2.73-14.79)。
  • 白蛋白尿风险比4.31(95%CI 0.95-19.58)。
  • 慢性肾脏病风险比2.03(95%CI 0.58-7.32)。

临床怎么用

  • 子痫前期患者产后应关注长期肾脏风险,尤其终末期肾病,需考虑随访策略。

局限性

  • 研究间异质性高,采用随机效应模型。
  • 定义不一致、随访不足和招募不完整可能导致差异。
  • 缺乏足够数据证明子痫前期与白蛋白尿和慢性肾脏病的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Preeclampsia is a pregnancy-related syndrome of variable severity, classically characterized by acute kidney involvement, with hypertension and/or proteinuria and reduced kidney function. Once considered a self-limited disease healed by delivery, it is now acknowledged that preeclampsia can affect cardiovascular and kidney health in the long term. The entity of risk has not been established and consequently follow-up policies have not been defined. Here we undertook a systematic review to gain better insights into the need for post-preeclampsia follow-up. Articles published between January 2000 and March 2018 were selected, dealing with at least 20 preeclampsia patients, with follow-up of 4 years or more (MEDLINE, Embase, and Cochrane Library). No quality selection or language restriction was performed. Of the 10,510 titles and abstracts originally considered, 21 papers were selected, providing information on 110,803 cases with and 2,680,929 controls without preeclampsia, with partial overlap between studies on the same databases. Heterogeneity was high, and a random meta-analytic model selected. The increase in risk of end stage renal disease after preeclampsia was significant (meta-analytic risk ratios (95% confidence interval) 6.35 (2.73-14.79)); the risk of albuminuria and chronic kidney disease increased but statistical significance was not reached (4.31 (0.95-19.58) and 2.03 (0.58-7.32), respectively). Translating meta-analytic risk into the number of patients who need follow-up to detect one adverse event, 310 patients with preeclampsia are needed to identify one woman with end stage renal disease or four to identify one woman with albuminuria. Heterogeneity in definitions, insufficient follow-up and incomplete recruitment may account for discrepancies. Thus, preeclampsia significantly increases the risk of end stage renal disease. However, there is lack of sufficient data to show a relationship between preeclampsia, albuminuria and chronic kidney disease, underlining the need for further prospective studies.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Covella B, Vinturache AE, Cabiddu G, et al. A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia. Kidney Int. 2019. PMID: 31352975. doi:10.1016/j.kint.2019.03.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。